NEWS, REPORTS & POSITION STATEMENTS 1. Urgent relaunch of the AFNOR S96R commission : F3OCI collective appeal The French organoid and organ-on-a-chip industry (F3OCI), alongside academic, industrial and biobank infrastructure players, published an open letter calling for the AFNOR S96R commission […]
NEWS, REPORTS & POSITION STATEMENTS 1. The drug development shift : Putting human biology at the center The biopharma industry continues to face unacceptable high attrition rates in clinical development. Most failures trace back to : 1. Lack of efficacy – animal […]
NEWS, REPORTS & POSITION STATEMENTS 1. Bringing scientific methods into regulatory guidelines Many innovative, animal-free methods never make it into official regulatory frameworks — not because they lack scientific value, but because navigating the path to acceptance is complex. A new article […]
The NAM newsletter will be back in September Wishing you a beautiful summer NEWS, REPORTS & POSITION STATEMENTS 1. DILI detection : Building Confidence in MPS for Regulatory Applications At the intersection of innovation, collaboration, and science lies an exciting […]
NEWS, REPORTS & POSITION STATEMENTS 1. ECHA updated report on Key Areas of Regulatory Challenge The European Chemicals Agency (ECHA) has updated its report on Key Areas of Regulatory Challenge with new topics in line with the European Union’s Competitiveness […]